满￥6666，赠豪华版黑神话悟空
Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 抑制剂/激动剂 /
维生素D相关/核受体
内分泌学/激素
/ 雄激素受体 / EPI-001

EPI-001 98%

货号：A201832 Ambeed 开学季，买赠积分，赢豪礼

EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of ∼6 μM and a selective PPAR-gamma modulator.

EPI-001 化学结构 CAS号：227947-06-0
EPI-001 化学结构
CAS号：227947-06-0
EPI-001 3D分子结构
CAS号：227947-06-0
EPI-001 化学结构 CAS号：227947-06-0
EPI-001 3D分子结构 CAS号：227947-06-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

EPI-001 纯度/质量文件 产品仅供科研

货号：A201832 标准纯度： 98%
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Nat. Commun., 2024, 15, 7687. Ambeed. [ A119633 ]
• ACS Nano, 2024. Ambeed. [ A1194179 ]
• J. Mol. Cell. Cardiol., 2024, 196, 94-104. Ambeed. [ A133052 ]
• iScience, 2024, 110928. Ambeed. [ A1375212 ]
• Mol. Pharmaceutics, 2024. Ambeed. [ A305202 , A409401 ]
更多 >
产品名称 Androgen Receptor ↓ 其他靶点 纯度
Cyproterone acetate ++++

Androgen Receptor, IC50: 7.1 nM

 		98%
Apalutamide +++

Androgen Receptor, IC50: 16 nM

 		98%
AZD3514 +

Androgen Receptor, Ki: 2.2 μM

 		98%
Darolutamide ++++

Androgen receptor, Ki: 11 nM

 		98%
Flutamide +++

Androgen Receptor, Ki: 55 nM

 		98%
Galeterone ++

Androgen Receptor, IC50: 384 nM

 		98%
Enzalutamide +++

Androgen Receptor, IC50: 36 nM

 		98%
Megestrol ✔ 98%
Bicalutamide ++

Androgen Receptor, IC50: 0.16 μM

 		99%
EPI-001 +

Androgen Receptor, IC50: ~6 μM

 		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

EPI-001 生物活性

靶点

  • Androgen Receptor

    Androgen Receptor, IC50:~6 μM
描述 Androgen receptor (AR) is a member of the steroid hormone receptor family, and plays important role in the physiology and pathology of diverse tissues. EPI-001is an androgen receptor antagonist with an IC50 value of approximately 6μM for inhibition of transactivation of the androgen receptor N-terminal domain[3]. EPI-001 (50 μM) inhibits transcriptional activity of both AR TAU1 and TAU5, and it also inhibits endogenous AR mRNA and protein expression. EPI-001(50 μM)is also a selective modulator of PPARγ in PCa cells[4]. In vivo, EPI-001 blocks the androgen-axis and inhibits androgen-dependent tumor growth. Intravenous injection (i.v.) of EPI-001 (50mg/kg body weight) significantly reduced the weight of prostates from intact mice compared with control-treated animals. Similarly, LNCaP subcutaneous (s.c.) xenografts from intact male mice treated with EPI-001 by i.v. were significantly reduced in volume[3].

EPI-001 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01839760 - Completed - United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States, 60611 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Canada, Ontario North York General Hospital Toronto, Ontario, Canada, M2K 1E1 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 收起 <<
NCT02188004 - Completed - China, Guangxi ... 展开 >> Liuzhou Center of disease prevention and control Liuzhou, Guangxi, China 收起 <<
NCT02645396 - Active, not recruiting December 2018 China, Fujian ... 展开 >> Maternity and Child care of Huli District Xiamen, Fujian, China, 361000 China, Henan Maternity and Child care of Xinmi City Zhengzhou, Henan, China, 450000 收起 <<

EPI-001 参考文献

[1]Brand LJ, Olson ME, et al. EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. Oncotarget. 2015 Feb 28;6(6):3811-24.

[2]Andersen RJ, Mawji NR, et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell. 2010 Jun 15;17(6):535-46.

[3]Andersen RJ, Mawji NR, Wang J, et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell. 2010;17(6):535-546.

[4]Brand LJ, Olson ME, Ravindranathan P, Guo H, Kempema AM, Andrews TE, Chen X, Raj GV, Harki DA, Dehm SM. EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. Oncotarget. 2015 Feb 28;6(6):3811-24.

EPI-001 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.66mL

2.53mL

1.27mL

25.32mL

5.06mL

2.53mL

EPI-001 技术信息

CAS号227947-06-0
分子式C21H27ClO5
分子量 394.889
别名
运输蓝冰
存储条件

粉末 Keep in dark place,Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月
溶解度

DMSO: 35 mg/mL(88.63 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方

Tags: EPI-001 | 227947-06-0 | EPI001 | EPI 001 | Androgen Receptor Inhibitor | Vitamin D Related/Nuclear Receptor | Metabolic Enzyme/Protease | Cell Cycle/DNA Damage | Apoptosis | Androgen Receptor | PPAR | Apoptosis | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | EPI-001 纯度/质量文件 | EPI-001 亚型比较 | EPI-001 生物活性 | EPI-001 临床数据 | EPI-001 参考文献 | EPI-001 实验方案 | EPI-001 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z